Rapid Dose Therapeutics Corp. (CSE:DOSE)

Canada · Delayed Price · Currency is CAD

0.1450

+0.0050 (3.57%)

Feb 9, 2026, 9:04 AM EST

Revenue by Product

Financials in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021	Feb '20 Feb 29, 2020	Feb '19 Feb 28, 2019
Contract Development Services	1.13M
Contract Development Services Growth	132.18%
White Label	906.62K
White Label Growth	98.40%
Nutraceuticals	25.55K
Nutraceuticals Growth	-18.88%
Product Testing	13.93K
Product Testing Growth	0.94%
Other Non-cannabis Product	9.28K
Other Non-cannabis Product Growth	43.31%

Revenue by Geography

Financials in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021	Feb '20 Feb 29, 2020	Feb '19 Feb 28, 2019
Canada	2.09M
Canada Growth	104.34%